When you expect high volatility ahead, this is a strategy that can help you profit no matter which way the stock goes. Read More
Scott Chan moved from China to the U.S. with family at the age of ten. He passed the rigorous entrance exam and attended the merit-based Stuyvesant High School, widely held to be best public school in New York City. He earned undergraduate degrees from New York University followed by an MBA degree from the Zicklin School of Business at Baruch College.
Shortly thereafter Scott partnered with Dr. Stephen Leeb on numerous financial publications. Today, he serves as the lead analyst for Real World Investing and The Complete Investor.
Mr. Chan is an avid baseball fan and enjoys outdoor activities in his spare time. A multicultural person, he reads Chinese and speaks fluent Mandarin and Cantonese Chinese.
Analyst Articles
Although options have a reputation of being risky, they can be used to reduce the risk of your stock holdings. Read More
Breakthroughs in biological drugs have enabled physicians to treat many diseases that have been resistant to conventional therapies. Read More
The FDA approved Biogen's Alzheimer's drug. That's great news for Biogen and its shareholders, but it's also fantastic news for a competitor. Read More
Some investors are scared off by the K-1 and UBTI when it comes to MLPs. Let's shed some light on those two factors. Read More
To prevent a devastating dividend cut, analyze a company's financial position. Earnings can tell you important information, but not the whole story. Read More
The VIX, aka the "fear index," is nothing to be afraid of. Instead, it could be a valuable source of information that helps you profit from market gyrations. Read More
Technology is always evolving, creating investment opportunities. Tech is changing the way financial services are delivered, too. Read More
Why slow and steady can add up to higher profits over time and how to calculate a more accurate return for your investments. Read More
Social distancing is revolutionizing medicine, as the coronavirus pandemic prompts many people to try telemedicine for the first time. Read More